Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC)

NACompletedINTERVENTIONAL

Enrollment

1,653

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

June 30, 2022

Conditions

Coronary Artery Disease

Interventions

DEVICE

Firehawk™ stent system

MicroPort Firehawk™ biodegradable polymer rapamycin target eluting stent

DEVICE

Abbott Xience family Everolimus-Eluting Stent

Trial Locations (1)

Rigshospitalet, Copenhagen

All Listed Sponsors

lead

Shanghai MicroPort Medical (Group) Co., Ltd.

INDUSTRY

NCT02520180 - Non-inferiority Study Comparing Firehawk Stent With Abbott Xience Family Stent (TARGET-AC) | Biotech Hunter | Biotech Hunter